Curis
CRIS
#10981
Rank
HK$5.29 M
Marketcap
HK$2.72
Share price
-17.89%
Change (1 day)
-80.10%
Change (1 year)

EPS for Curis (CRIS)

EPS in 2025 (TTM): -HK$28.58

According to Curis's latest financial reports the company's current EPS (TTM) is -HK$28.77. In 2024 the company made an earnings per share (EPS) of -HK$55.12 an increase over its 2023 EPS that were of -HK$70.80.

EPS history for Curis from 2011 to 2025

Annual EPS

Year EPS Change
2025 (TTM)-HK$28.58-48.15%
2024-HK$55.12-22.15%
2023-HK$70.80-26.17%
2022-HK$95.8922.3%
2021-HK$78.40-25.37%
2020-HK$105.06-30.93%
2019-HK$152.11-2.02%
2018-HK$155.24
2016-HK$352.82-10%
2015-HK$392.02138.1%
2014-HK$164.6540%
2013-HK$117.61-25%
2012-HK$156.8166.67%
2011-HK$94.09

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Pfizer
PFE
HK$10.27-135.69%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
HK$27.91-197.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Spectrum Pharmaceuticals
SPPI
-HK$2.82-90.19%๐Ÿ‡บ๐Ÿ‡ธ USA
Exelixis
EXEL
HK$24.54-185.29%๐Ÿ‡บ๐Ÿ‡ธ USA
Celldex Therapeutics
CLDX
-HK$30.50 5.99%๐Ÿ‡บ๐Ÿ‡ธ USA
Cel-Sci
CVM
-HK$88.13 206.27%๐Ÿ‡บ๐Ÿ‡ธ USA
Emergent BioSolutions
EBS
HK$11.06-138.42%๐Ÿ‡บ๐Ÿ‡ธ USA